Target intelligence / Profile preview

Neuroplastin (NPTN)

Target
NPTN
Molecular classification
Cell adhesion molecule (Immunoglobulin superfamily), Type I transmembrane protein
01

Overview

Neuroplastin is a cell adhesion molecule encoded by the NPTN gene and a member of the immunoglobulin superfamily, present as multiple isoforms (notably np65, brain-specific, and np55, ubiquitous). It mediates cell-cell and cell-substrate interactions in the nervous system, especially at synapses. It plays critical roles in synaptic plasticity mechanisms essential for learning and memory, including long-term potentiation, and participates in neurite outgrowth and synapse maturation via signaling cascades such as the MAPK pathway and FGFR1 signaling. Neuroplastin is also a key auxiliary protein for plasma membrane calcium ATPases, regulating neuronal calcium homeostasis and modulating synaptic function. It is highly expressed in the brain, with emerging evidence for roles in cognition, neurodevelopmental and psychiatric disorders, neurodegenerative changes, and even as a molecular gatekeeper for cell energy metabolism by chaperoning monocarboxylate transporters. Although genetically and pathophysiologically linked to several diseases, neuroplastin is not currently a direct therapeutic target, and no drugs are known to modulate its function in clinical practice[1][2][3][4][5].

Other names
SDFR1SDR1SDR-1GP55GP65np65np55Stromal cell-derived receptor 1stromal cell derived factor receptor 1
02

Biological functions

Cell adhesion (homophilic and heterophilic)Synaptic plasticity (including long-term potentiation and depression)Regulation of neurite outgrowthModulation of hippocampal synaptic functionRegulation of calcium homeostasis via plasma membrane calcium ATPasesEnergy metabolism via monocarboxylate transporter (MCT2) localization
03

Disease associations

Neurodegenerative disease (implicated in Alzheimer's disease, tissue response after ischemia)Neurodevelopmental disorder (autism, schizophrenia)Cognitive disorders (intellectual ability, cortical thickness)Cancer (linked with breast cancer)Hearing loss (mutations affect auditory function)
04

Safety considerations

None specifically reported; not a therapeutically targeted molecule at present
05

Biomarkers

Polymorphisms in the NPTN gene have been linked to intelligence performance, cortical thickness, and risk for schizophrenia.Changes in neuroplastin expression suggested as markers in neurodegeneration (e.g. Alzheimer’s) and development

Beyond the preview

Go deeper on Neuroplastin (NPTN).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neuroplastin (NPTN).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call